PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury

Journal of Nuclear Medicine

Volumn 54, Issue 5, 2013, Pages 785-792

  Wang, Jiachuan ^a,b,c   Chao, Fangfang ^a,b,c   Han, Feng ^b   Zhang, Gensheng ^b   Xi, Qunying ^a,b,c   Li, Jinhui ^a,b,c   Jiang, Han ^a,b,c   Wang, Jing ^a,b,c   Yu, Gang ^a,b,c   Tian, Mei ^a,b,c   Zhang, Hong ^a,b,c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Key Laboratory of Medical Molecular Imaging of Zhejiang Province   (China)

Author keywords

Cerebral ischemia; Induced pluripotent stem cells; Positron emission tomography (PET); Transplantation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANALYTICAL EQUIPMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN RADIOGRAPHY; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FUNCTIONAL ASSESSMENT; GLUCOSE METABOLISM; HISTOPATHOLOGY; IMAGING SOFTWARE; LATERAL BRAIN VENTRICLE; MALE; NEUROLOGIC EXAMINATION; NONHUMAN; PET SCANNER; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; TREATMENT RESPONSE;

CEREBRAL ISCHEMIA; INDUCED PLURIPOTENT STEM CELLS; POSITRON EMISSION TOMOGRAPHY (PET); TRANSPLANTATION;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FLUORODEOXYGLUCOSE F18; INDUCED PLURIPOTENT STEM CELLS; MALE; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION;

EID: 84877154299     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.111112     Document Type: Article

References (38)

1. Kleinschnitz C, Grund H, Wingler K, et al. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 2010;8:e1000479.
2. Theus MH, Wei L, Cui L, et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol. 2008;210:656-670.
3. Wei L, Cui L, Snider BJ, et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis. 2005;19:183-193. (Pubitemid 40544735)
4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676. (Pubitemid 44233629)
5. Jensen MB, Yan H, Krishnaney-Davison R, Al Sawaf A, Zhang SC. Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. J Stroke Cerebrovasc Dis. November 10, 2011 [Epub ahead of print].
6. Karumbayaram S, Novitch BG, Patterson M, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009;27:806-811.
7. Kitazawa A, Shimizu N. Differentiation of mouse induced pluripotent stem cells into neurons using conditioned medium of dorsal root ganglia. N Biotechnol. 2011;28:326-333.
8. Hargus G, Cooper O, Deleidi M, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A. 2010;107:15921-15926.
9. Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A. 2010;107:12704-12709.
10. Nori S, Okada Y, Yasuda A, et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A. 2011;108:16825-16830.
11. Jiang M, Lv L, Ji H, et al. Induction of pluripotent stem cells transplantation therapy for ischemic stroke. Mol Cell Biochem. 2011;354:67-75.
12. Yamashita T, Kawai H, Tian F, Ohta Y, Abe K. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant. 2011;20:883-891.
13. Chen SJ, Chang CM, Tsai SK, et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev. 2010;19:1757-1767.
14. Kawai H, Yamashita T, Ohta Y, et al. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab. 2010;30:1487-1493.
15. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev. 2010;19:1017-1023.
16. Zhang Y, Ruel M, Beanlands RS, deKemp RA, Suuronen EJ, DaSilva JN. Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr Pharm Des. 2008;14:3835-3853.
17. Jiang H, Cheng Z, Tian M, Zhang H. In vivo imaging of embryonic stem cell therapy. Eur J Nucl Med Mol Imaging. 2011;38:774-784.
18. 18F-FDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury. Eur J Nucl Med Mol Imaging. 2008;35:1699-1708.
19. Muramatsu S, Okuno T, Suzuki Y, et al. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. Synapse. 2009;63:541-548.
20. Jackson J, Chapon C, Jones W, Hirani E, Qassim A, Bhakoo K. In vivo multimodal imaging of stem cell transplantation in a rodent model of Parkinson's disease. J Neurosci Methods. 2009;183:141-148.
21. Shyu WC, Li KW, Peng HF, et al. Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model. J Neurosci Res. 2009;87:2020-2033.
22. Visnyei K, Tatsukawa KJ, Erickson RI, et al. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neurol. 2006;197:465-474. (Pubitemid 43077155)
23. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academy Press; 2011.
24. Zhu M, Ackerman JJ, Yablonskiy DA. Body and brain temperature coupling: the critical role of cerebral blood flow. J Comp Physiol B. 2009;179:701-710.
25. Curtin LI, Grakowsky JA, Suarez M, et al. Evaluation of buprenorphine in a postoperative pain model in rats. Comp Med. 2009;59:60-71.
26. Sugiura S, Kitagawa K, Tanaka S, et al. Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke. 2005;36:859-864.
27. Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682-2688. (Pubitemid 33055324)
28. 18F-FDG PET demonstrates benefit of human mesenchymal stem cells in treatment of intracerebral hematoma: a translational study in a primate model. J Nucl Med. 2011;52:90-97.
29. Sadan O, Shemesh N, Barzilay R, et al. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease. Exp Neurol. 2012;234:417-427.
30. Narantuya D, Nagai A, Sheikh AM, et al. Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS ONE. 2010;5:e11746.
31. Kilic U, Kilic E, Dietz GP, Bahr M. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke. 2003;34:1304-1310. (Pubitemid 36547533)
32. Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res. 2006;84:1495-1504. (Pubitemid 44683142)
33. Zhu JM, Zhao YY, Chen SD, Zhang WH, Lou L, Jin X. Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia. J Int Med Res. 2011;39:488-498.
34. Toyama K, Honmou O, Harada K, et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol. 2009;216:47-55.
35. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2007;2:3081-3089.
36. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872. (Pubitemid 350138099)
37. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS ONE. 2010;5:e8975.
38. Hu BY, Zhang SC. Directed differentiation of neural-stem cells and subtype-specific neurons from hESCs. Methods Mol Biol. 2010;636:123-137.